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Praneet Chaturvedi 
 
Role of Post-transcriptional regulation in human liver 
                                                                         
 
Abstract 
My thesis comprises of two individual projects which revolve around the importance of post-
transcriptional regulation in liver. My first project is studying the integrated miRNA – mRNA 
network in NAFLD. For fulfillment of the study we conducted a genome-wide study to identify 
microRNAs (miRs) as well as the miR-mRNA regulatory network associated with hepatic fat and 
NAFLD. Hepatic fat content (HFC), miR and mRNA expression were assessed in 73 human 
liver samples. Liver histology of 49 samples was further characterized into normal (n=33) and 
NAFLD (n=16).  Liver miRNome and transcriptome were significantly associated with HFC and 
utilized to (a) build miR-mRNA association networks in NAFLD and normal livers separately 
based on the potential miR-mRNA targeting and (b) conduct pathway enrichment analyses. We 
identified 62 miRs significantly correlated with HFC (p < 0.05 with q < 0.15), with miR-518b and 
miR-19b being most positively and negatively correlated with HFC, respectively (p < 0.008 for 
both).  Integrated network analysis showed that six miRs (miRs-30b*, 612, 17*, 129-5p, 204 and 
20a) controlled ~ 70% of 151 HFC-associated mRNAs (p < 0.001 with q < 0.005). Pathway 
analyses of these HFC-associated mRNA revealed their key effect (p<0.05) in inflammation 
pathways and lipid metabolism. Further, significant (p<2.47e-4, Wilcoxon test) reduction in 
degree of negative associations for HFC-associated miRs with HFC-associated mRNAs was 
observed in NAFLD as compared to normal livers, strongly suggesting highly dysfunctional miR-
mRNA post-transcriptional regulatory network in NAFLD. Our study makes several novel 
observations which provide clues to better understand the pathogenesis and potential treatment 
targets of NAFLD. 
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My second project is based on uncovering important players of post-transcriptional regulation 
(RBPs) and how they are associated with age and gender during healthy liver development. For 
this study, we performed an association analysis focusing on the expression changes of 1344 
RNA Binding proteins (RBPs) as a function of age and gender in human liver. We identify 88 
and 45 RBPs to be significantly associated with age and gender respectively. Experimental 
verification of several of the predicted associations in the mouse model confirmed our findings. 
Our results suggest that a small fraction of the gender-associated RBPs (~40%) are likely to be 
up-regulated in males. Altogether, these observations show that several of these RBPs are 
important developmentally conserved regulators. Further analysis of the protein interaction 
network of RBPs associated with age and gender based on the centrality measures like degree, 
betweenness and closeness revealed that several of these RBPs might be prominent players in 
liver development and impart gender specific alterations in gene expression via the formation of 
protein complexes. Indeed, both age and gender-associated RBPs in liver were found to show 
significantly higher clustering coefficients and network centrality measures compared to non-
associated RBPs. The compendium of RBPs and this study will help us gain insight into the role 
of post-transcriptional regulatory molecules in aging and gender specific expression of genes. 
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Chapter 1 Introduction 
 
 
1.1 Understanding the post-transcriptional regulation 
                     
Post-transcriptional regulation is mainly carried out by two important players 1) 
miRNAs 2) RBPs. Post-transcriptional control is important when degradation of 
transcripts is required, providing support or translocation ability to transcripts, 
translation to proteins etc. also it is very important in organ development and when 
studying causes of disease in an organism. Let’s see what miRNAs are : 
MicroRNAs (miRs) are small (~20nt) non-coding RNA molecules that regulate 
gene expression through either transcript degradation [1] or translational 
repression [2]. miRs have been predicted to regulate 30% of human genes [3] with 
bioinformatics analysis indicating that thousands of genes could be controlled by 
single miR [4] forming a dense network of post-transcriptional interactions [5]. In 
particular, miRs are documented as key players in the regulation of genes involved 
in lipid metabolism [6], glucose metabolism [7], energy homeostasis [8] and many 
other related biological processes like cell proliferation, apoptosis, lymphocyte 
development, adipocyte differentiation, and insulin secretion [9]. Several studies 
also reveal that miRs could act as oncogenes [10] or tumor suppressors [11] with 
their dysregulation playing significant roles in promoting hepatocellular carcinoma 
[12]. On the other hand RBPs play different functions and are very important at 
post-transcriptional control/regulation. RNA Binding Proteins (RBPs) bind to RNA 
molecules to control different post transcriptional processes such as pre-mRNA 
splicing, mRNA cytoplasmic export, turnover, storage, and translation [13, 14]. 
Thus, the capacity of these proteins to influence gene expression at post-
transcriptional level is extremely important especially during the developmental 
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process to give rise to complex organs and tissues[15, 16]. 
 
1.2 What is NAFLD 
  
Non-Alcoholic Fatty Liver Disease (NAFLD) has emerged as a global problem with 
an incidence of ~ 30% in adults and ~ 10% in children and adolescents [17]. 
NAFLD can be broadly categorized into simple steatosis and steatohepatitis 
(NASH).  Simple steatosis is generally thought to be benign whereas NASH can 
progress to cirrhosis, liver failure and liver cancer [18-20].  Over the last decade, 
there have been many important advances which expanded our understanding of 
the pathogenesis of NAFLD and NASH, but significant knowledge gaps remain.  
 
1.3 Why miRNAs are of importance in NAFLD 
  
 A number of miRs have been identified to be associated with NAFLD and/or NASH 
in human livers [21, 22] as well as animal models [23, 24]. However, these studies 
have generally focused on miRs in a unidimensional fashion. Given the complexity 
of the interactions between miRs and mRNAs and the dependence of the function 
of miRs on mRNAs, it is of critical importance to understand the miR-mRNA 
regulatory network simultaneously in the same set of samples. 
 
1.4 Why RBPs are of importance in organ development 
 
RBPs play a substantial role in mediating developmental changes of a mammalian 
cell. For instance, PTBP1 (polypyrimidine tract binding protein), a ubiquitous protein 
known to be important in mammalian development at early stages of gastrulation 
[25, 26] and ELAVL1 (HuR) - a protein that acts as an mRNA stability factor, is also 
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known for its role in placental branching, embryonic and neuronal development. [27, 
28]. Likewise, CRD-BP (IGF2BP1), a member of the insulin-like growth factor 2 
mRNA-binding protein family, is the first example of a putative mammalian mRNA-
binding proteins that is abundant in fetal tissue but absent in the adult tissue [29]. 
Furthermore, a study on understanding the regulation of HNF4alpha in liver 
development revealed that the expression of HNF4aplha is widely regulated by the 
sequential promoter usage and alternative splicing in the 3’ end to produce different 
isoforms important for the liver development[30]. Yet another study identified UPF2, 
one of the key players of the non-sense mediated mRNA decay (NMD) machinery, 
as a critical regulator of the liver development [31]. Thus, although specific RBPs 
have been studied for their role in mediating developmental processes of liver, no 
global association analysis has been performed in humans to uncover the 
repertoire of RBPs contributing to liver development. 
 
1.5 What we have done 
                      
For the first study that is understanding integrated miR – mRNA network in    
NAFLD we have conducted a study with following objectives; (a) to assess 
genome-wide miRs and mRNAs that are significantly associated with hepatic fat 
concentration (HFC) in human liver tissue; (b) to build miR-mRNA association 
networks based on the potential miR-mRNA targeting that distinguish NAFLD from 
normal liver tissue; and (c) to conduct a pathway enrichment analysis of NAFLD. 
For the second study that is uncovering the RBPs associated as a function of age 
and gender during liver development we did a genome-wide association analysis of 
their expression patterns with age and gender was conducted. To achieve this, we 
performed an association analysis of RBPs expression levels in human liver 
tissues with respect to age and gender, by integrating a dataset of 1344 genes 
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experimentally known to encode for RBPs. This allowed us to catalogue for the first 
time age and gender-related associations for RBPs as well as to study the wiring 
patterns of RBPs and their protein complexes (protein-protein interaction networks) 
with liver development in the human genome. 
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Chapter 2 Integrated Network Analysis Uncovers Key microRNAs, microRNA-mRNA Regulatory 
Networks and Related Pathways Associated with Human Hepatic Fat Accumulation 
 
2.1 Introduction 
 
Non-Alcoholic Fatty Liver Disease (NAFLD) has emerged as a global problem with an 
incidence of ~ 30% in adults and ~ 10% in children and adolescents [17]. NAFLD can be 
broadly categorized into simple steatosis and steatohepatitis (NASH).  Simple steatosis is 
generally thought to be benign whereas NASH can progress to cirrhosis, liver failure and liver 
cancer [18-20].  Over the last decade, there have been many important advances which 
expanded our understanding of the pathogenesis of NAFLD and NASH, but significant 
knowledge gaps remain.  
MicroRNAs (miRs) are small (~20nt) non-coding RNA molecules that regulate gene 
expression through either transcript degradation [1] or translational repression [2]. miRs have 
been predicted to regulate 30% of human genes [3] with bioinformatics analysis indicating 
that thousands of genes could be controlled by single miR [4] forming a dense network of 
post-transcriptional interactions [5]. In particular, miRs are documented as key players in the 
regulation of genes involved in lipid metabolism [6], glucose metabolism [7], energy 
homeostasis [8] and many other related biological processes like cell proliferation, apoptosis, 
lymphocyte development, adipocyte differentiation, and insulin secretion [9]. Several studies 
also reveal that miRs could act as oncogenes [10] or tumor suppressors [11] with their 
dysregulation playing significant roles in promoting hepatocellular carcinoma [12]. To date, a 
number of miRs have been identified to be associated with NAFLD and/or NASH in human 
livers [21, 22] as well as animal models [23, 24]. However, these studies have generally 
focused on miRs in a unidimensional fashion. Given the complexity of the interactions 
between miRs and mRNAs and the dependence of the function of miRs on mRNAs, it is of 
critical importance to understand the miR-mRNA regulatory network simultaneously in the 
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same set of samples.  
In order to further our understanding of pathogenesis of fat accumulation and NAFLD in 
humans, we have conducted a study with following objectives; (a) to assess genome-wide 
miRs and mRNAs that are significantly associated with hepatic fat concentration (HFC) in 
human liver tissue; (b) to build miR-mRNA association networks based on the potential miR-
mRNA targeting that distinguish NAFLD from normal liver tissue; and (c) to conduct a 
pathway enrichment analysis of NAFLD. 
 
2.2 Materials and Methods 
 
2.2.1 Samples and genomic datasets 
Seventy three human liver tissue samples collected from transplant donors were used in this 
study. The sample procurement procedure and related information were described in our 
previous study [32, 33].  In brief, these transplant donors lacked heavy alcohol consumption 
and tested negative for viral hepatitis B and C.  Their demographics and available clinical 
characteristics were shown in Table S1. The mRNA expression was analyzed using the 
Agilent expression arrays (Agilent-014850 4×44k arrays, GPL4133) [32], and expression of 
850 miRNAs was analyzed using the Exiqon miRCURY™ LNA Array v10.0 (Exiqon, Inc., 
Denmark) [33].  Purdue University IRB has approved this study. 
 
2.2.2 Measurement of hepatic fat content  
Total hepatic fat content (HFC) of 73 human liver samples was quantified using a modified 
hexane/isopropanol method according to our previously established protocol [34]. Total 
hepatic protein content among these samples was also measured by the standard Bradford 
method. Total HFC was then normalized to the protein content and expressed as fat/protein 
weight ratio. 
2.2.3 Histopathological evaluation 
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Sufficient liver tissue was available from 49 liver samples for histopathological assessment.    
Approximately, 10 mg of their liver tissue was fixed in 10% formalin and embedded in 
paraffin. The tissue blocks were then sectioned and stained with H&E and Masson’s 
trichrome stains. An expert hepatopathologist in a blinded fashion classified samples into 
normal (n=33) and NAFLD (n=16). The latter was further sub-classified into fatty liver (n=2), 
borderline NASH (n=9), and NASH (n=5) categories based on the NASH CRN criteria [35] 
(Table S1).  Additional histological characterization included estimation for the degree of 
steatosis (%), hepatocytes ballooning, lobular inflammation, Mallory bodies, NAFLD Activity 
Score (NAS) and fibrosis. Histological examination revealed no other incidental causes for 
chronic liver disease (e.g., iron overload, alpha-1 antitrypsin inclusions, autoimmune 
hepatitis, granulomas or biliary tract disease).  
 
2.2.4 Association of miRs and mRNA expression profiles with hepatic fat content 
 
Expression profiles of 850 miRs of 73 liver samples were compared with their HFC to identify 
the miRs that are most correlated with HFC. Spearman correlation was calculated between 
miR expression and HFC, to identify miRs significantly (p < 0.05) correlated with HFC with q-
value less than 0.15 using the fdrtool [36].  
In a separate analysis, spearman correlations were calculated for the complete 
transcriptomic data of 73 liver samples to identify the transcripts that are most correlated with 
HFC. Significantly correlated (p < 0.001 and q-value less than 0.005 using  fdrtool [36]) 
mRNAs (genes) were analyzed by Panther-GO ontology bioinformatics tool to categorize the 
functional classes of these genes in biological processes [37]. These HFC-associated genes 
were considered for further pathway enrichment analysis by using bioinformatic tools 
including Panther [38], DAVID [39] and G-profiler [40].   
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2.2.5 Prediction of genes targeted by miRs 
 
Both miRs and mRNAs which were found correlated with HFC values across 73 samples 
were further analyzed for their possible miR–target mRNA association using miR target 
prediction tools, TargetScan [4] and miRanda [41, 42]. TargetScan prediction is based on the 
occurrence of conserved 7-8mer seed region of a miRNA in 3’-untranslated region (UTR) of 
its biological targets, followed by their rank based scoring of conserved overlapping 
probability [43]. Similarly, miRanda is another algorithm which allows the prediction of 
genome-wide targets of miRs and is largely complementary to TargetScan as it does not use 
conservation information. In particular, miRanda is a machine learning method for ranking 
microRNA target sites by a down-regulation score by integrating gene expression and 
sequence level features. The algorithm trains a regression model on sequence and 
contextual features extracted from high confidence miRanda-predicted target sites and hence 
can predict non-canonical and non-conserved sites as well [42]. To predict the mRNA targets 
of each of the miRNAs in this study, 3’-UTR for the complete set of genes in the human 
genome were downloaded from Ensembl biomart [44, 45] and fasta sequences for miRs 
were downloaded from miRBase [46]. miRNA target sites on each of the mRNAs correlated 
with HFC were predicted using both the methods at default thresholds. A gene was 
considered to be targeted by a miRNA if either of the methods predicted it as a target. This 
allowed the construction of a HFC associated miRNA-mRNA interaction network which was 
visualized using cytoscape [47]. Association between each miR and mRNA correlated with 
HFC represented as a matrix, was also shown as a heatmap using Java Tree view [48]. Also, 
a subset of this interaction network was further generated to show most important genes and 
associated miRs that could be involved in various biological pathways associated with HFC.  
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2.2.6 Investigating the relationship between HFC and other variables   
 
Using a nonparametric test (Wilcoxon test), the HFC was compared between normal and 
NAFLD (and its subclasses) and are represented as box plots. Similar approach was adopted 
to investigate the influence of additional variables like age, gender and race on HFC.  Since 
gender and race were not found to be associated with HFC, the expression profiles of the 62 
miRNAs significantly correlated with HFC across the 73 liver samples together with the age 
were used for a Principal Component Analysis (PCA) to test the influence of age in explaining 
the association of miRNAs with HFC. 
 
2.2.7 Dynamics of miR-mRNA association network in NAFLD 
 
We constructed miR-mRNA association networks for NAFLD (n=16) and normal (n=33) 
groups separately by calculating the correlation between miRNA and mRNA levels across the 
samples. This was achieved by calculating the Spearman correlation between each pair of 
miRNA-mRNA expression levels across the 16 NAFLD samples and 33 normal samples and 
identifying those pairs which exhibited a negative correlation with a p-value < 0.001 
threshold. The degree of association of each miR with mRNAs was defined for each group as 
the number of mRNAs which are negatively correlated in expression at a significant 
correlation (p < 0.001). Additionally, degree ratio in miR-mRNA association networks for 
these two groups for each miR was calculated. We also employed the miRNA target 
predictions identified by both the methods (TargetScan and miRanda) to further filter the 
above association networks to contain only the predicted targets and obtain the ratio of the 
number of mRNA targets between the two groups. This analysis allowed us to visualize the 
global effect of the dysregulation of miRNAs independently found to be associated with HFC 
in two groups separately.   
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2.3 Results 
 
Overall study scheme and sample size for various analyses are shown in Figure 1. In brief, 
HFC, miR and mRNA analyses were performed on 73 human liver samples whereas 
histological characterization was performed on 49 liver samples.  
 
Figure 1. Work flow. Liver samples were collected from 73 organ transplant donors for our 
study. The miRnome and transcriptome profiles for these 73 samples were generated by 
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microarray experiments. Subsequently, miRnome and transcriptome data were correlated 
(Spearman correlation) separately with hepatic fat content (HFC) of 73 individuals. HFC 
associated 163 mRNAs (151 genes) were analyzed for their enrichment in several biological 
pathways. Additionally 129 targets, predicted by miRanda or TargetScan, miRNA target 
prediction algorithms, for HFC associated 62 miRs were found as an overlapped subset of 
HFC associated mRNAs (151 genes). HFC affected miR-mRNA interaction network (62 miRs 
connected to 129 genes with 1972 edges) was generated and a subset of this network was 
studied for HFC influenced dysregulated biological pathways. Similarly, in a subset of 49 
samples (33 Normal and 16 NAFLD), miR and mRNA expression data were correlated (p < 
0.001) separately for each group and degree ratio between negatively correlated miR-mRNA 
interaction for normal and NAFLD groups was calculated and interpreted to understand the 
dynamics of post transcriptional regulatory network in NAFLD.  
 
2.3.1 A significant number of miRs were associated with hepatic fat accumulation  
 
Our analysis identified 62 miRs significantly correlated with HFC levels (p < 0.05 with q < 
0.15). Table S2 shows a complete list of these miRNAs along with their correlation coefficient 
and significance. Notably, many miRs previously described to be functionally important for 
liver disorders (e.g., fatty liver, hepatitis, cirrhosis and liver neoplasia) were among these 62 
significant miRs (miR-34a, miR-142-3p, miR-150 and miR-122 were found to be positively 
correlated while miR-26a/b, miR-215-5p, miR-194, miR-101, miR-30b/e were negatively 
correlated with HFC). Selected set of these positively and negatively correlated miRNAs with 
experimental support from the literature are shown in Table 1. Besides these miRs with 
known function in liver diseases, we also identified a few new miRs including miR-518b and 
miR-19b which exhibited most significant positive and negative correlations with HFC, 
respectively (p < 0.009 for both) (Table 1). 
 
Table 1: Selected set of HFC associated miRs with their documented roles in various liver 
disorders.  (NA refers to data/ study not available) 
 
miR 
Correlatio
n indices 
p value Liver Disorders 
miR-518b 0.681965 8.64E-03 NA 
miR-497 0.529583 5.16E-02 NA 
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miR-204 0.467266 3.02E-02 NA 
miR-339-5p 0.433866 1.21E-02 NA 
miR-150 0.397664 4.60E-02 
Liver Neoplasms [49] 
Liver Diseases [50]  
Liver Cirrhosis [51] 
Hepatoblastoma [52] 
miR-142-3p 0.347483 3.78E-03 Liver Diseases [53] 
miR-129-5p 0.339155 4.00E-02 NA 
miR-34a 0.337861 3.11E-03 
Alcoholic liver disease [54] 
Fatty Liver [55] 
Liver Diseases [55] 
Liver Cirrhosis [54]  
Hepatitis [56] 
Liver Neoplasms [56] 
Hepatitis C [57] 
miR-381 0.33767 1.01E-02 NA 
miR-30b* 0.32129 5.47E-03 Hepatitis [58] 
miR-26b -0.38147 7.77E-04 Liver Neoplasms [59] 
miR-30b -0.38153 7.53E-04 Hepatitis [58] 
miR-30e -0.38812 5.41E-04 Hepatitis [58] 
miR-19a -0.38933 5.10E-04 NA 
miR-378 -0.39209 4.25E-04 NA 
miR-101 -0.39378 4.45E-04 
Hepatitis B [60] 
Liver Cirrhosis [61] 
Liver Neoplasm [62] 
miR-194 -0.39651 3.70E-04 
Hepatitis [63] 
Liver Cirrhosis [51] 
miR-215-5p -0.41136 1.98E-04 
Hepatitis [64] 
Liver Cirrhosis [64] 
miR-26a -0.41603 2.69E-04 
Hepatitis B [65] 
Hepatitis Chronic [65] 
Liver Neoplasms [65] 
Liver Diseases [66] 
Biliary Cirrhosis [67] 
miR-19b -0.42251 1.41E-04 NA 
 
 
2.3.2 HFC associated dysregulation of mRNAs  
 
We calculated the correlation between HFC of 73 liver samples and their hepatic 
transcriptomes which allowed the identification of mRNAs most correlated with fat 
accumulation.  A total of 163 probes corresponding to 151 genes were significantly correlated 
(p < 0.001 with q < 0.005) with HFC and are listed in Table S3. A selected set of highly 
 18 
 
correlated mRNAs with HFC (10 positively and 10 negatively) are shown in Table 2.  
 
Table 2: Selected set of mRNAs (genes) highly (10 positively and 10 negatively) correlated with 
hepatic fat concentration (with a brief description) 
 
mRNA 
probe ID 
UniProt 
Gene 
name 
Correlati
on indices 
p-value Description (Using ensembl.org) 
5052 STMN2 0.465248 3.36E-05 Stathmin-like 2 
20785 LAMA1 0.46079 4.09E-05 Laminin, alpha 1 
1488 MYO1F 0.460682 4.11E-05 Myosin IF 
24614 PTGS1 0.450886 6.25E-05 
Prostaglandin-endoperoxide synthase 1 
(prostaglandin G/H synthase and cyclooxygenase) 
3320 GAS6 0.444646 9.11E-05 Growth arrest-specific 6 
10883 CLSTN1 0.444546 8.14E-05 Calsyntenin 1 
975 IGKC 0.438066 1.06E-04 Immunoglobulin kappa constant 
14674 CD86 0.43404 1.25E-04 CD86 molecule 
19605 EEF1A2 0.432143 1.35E-04 Eukaryotic translation elongation factor 1 alpha 2 
16262 
DKFZP434
G032 
0.429165 1.52E-04 Keratin 23 (histone deacetylase inducible) 
3472 FBXO5 -0.42076 2.10E-04 F-box protein 5 
25839 IPO5 -0.42378 1.87E-04 Importin 5 
7496 EFCAB3 -0.42458 1.81E-04 EF-hand calcium binding domain 3 
6656 CYP20A1 -0.42482 2.00E-04 
Cytochrome P450, family 20, subfamily A, 
polypeptide 1 
22079 C16ORF35 -0.42893 1.53E-04 Nitrogen permease regulator-like 3 (S. cerevisiae) 
6102 CYP51A1 -0.42998 1.47E-04 
Cytochrome P450, family 51, subfamily A, 
polypeptide 1 
12276 KRTCAP3 -0.43128 1.39E-04 Keratinocyte associated protein 3 
19215 ZNF518B -0.446 7.67E-05 Zinc finger protein 518B 
18862 EIF4E2 -0.45567 5.10E-05 
Eukaryotic translation initiation factor 4E family 
member 2 
1325 CXORF57 -0.48472 1.39E-05 Chromosome X open reading frame 57 
 
 
2.3.3 Potential targets that could be controlled by combined effect of HFC associated miRs 
 
Target prediction for 62 HFC associated miRNAs was performed by using two publicly 
available prediction tools TargetScan and miRanda as described in Materials and Methods 
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(Table S4). The list of target genes for these miRNAs which overlapped with the list of 
mRNAs also significantly correlated with HFC (from Table S3), were used to generate 
miRNA-mRNA interactions. This is represented as a heatmap of miR-mRNA interactions 
showing 62 miRs targeting among 129 protein coding genes (mRNA), each also significantly 
correlated with HFC (Figure 2 and Table S5).  Interestingly, six miRs (miRs-30b*, 612, 17*, 
129-5p, 204 and 20a) were found to control ~ 70% of 151 HFC-associated mRNAs in this 
network, with an average connectivity of ~32 targets for each miRNA indicating the dense 
networking between these HFC-associated miRNAs and mRNAs. The degree of association 
of each of the miRs in this resulting interaction network is shown in Table S6, among which 
miR-30b* was found to be highly associated and miR-487b-3p was least connected. 
 
 
 
Figure 2. HFC associated miR-mRNA (gene) interaction network. miRnome and 
transcriptome expression profiles were correlated separately with HFC of 73 individuals and 
each miR predicted target mRNA (gene) is shown as miR-mRNA heatmap. It includes 62 
HFC associated miRs and 129 HFC associated target genes with blue colored box as target 
and green colored box as non-target.  
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2.3.4 Role of HFC associated mRNAs in biological processes  
 
Panther-Gene Ontology analysis provided an initial snapshot of the involvement of HFC-
associated 151 genes in various classes of biological processes. Figure 3a shows the 
various biological processes and their contribution to the list of 151 genes identified to be 
associated with HFC, with metabolic processes (45.3%), cellular processes (40.2%), and cell 
communication (32.5%), immune system processes (18.0%) forming the core set of 
processes associated with fat accumulation (Table S7 shows all the biological processes 
identified in this analysis).  
HFC associated 151 genes (mRNAs) were further analyzed independently by three different 
pathway enrichment tools, namely  Panther [38], DAVID [39] and G-profiler [40] functional 
analysis systems to have a comprehensive and unbiased overview of the enriched functional 
themes. This analysis revealed that inflammation pathways mediated by chemokine and 
cytokine signaling, Wnt signaling, B cell activation, NK cell mediated cytotoxicity and lipid 
metabolism pathways were significantly enriched (p < 0.05).  List of enriched pathways 
identified by each of these tools are documented in Tables S8, S9 and S10 respectively and 
also shown as pie charts (Figure 3b, 3c and 3d). One of the highly enriched pathways is 
shown in Figure 3e with several HFC associated genes marked in red. This pathway 
comprises of several cell adhesion molecules involved in various cascades of immunity and 
signaling pathways like T-cell receptor, complement and coagulation cascade and leukocyte 
transendothelial migration of dendritic cells, macrophages, TH cell, B cell, etc. Additionally, 
some of affected pathways and the HFC associated genes identified in them are shown in 
Figures S1, S2 and S3. 
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Figure 3. Role of HFC associated genes (mRNA) in several biological pathways. HFC 
associated 151 genes were analyzed for possible biological significance. These genes were 
analyzed for their role in various biological processes using (a) PANTHER-Gene ontology 
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tool and their highly enriched pathways predicted by (b) PANTHER (c) DAVID and (d) g-
Profiler tools are shown as pie charts respectively; (e) One of the pathways predicted by 
DAVID, includes cell adhesion molecules, that could be highly affected by dysregulation of 
associated genes (red asterisk) is shown in figure 3(e). 
 
Two major classes of biological processes, lipid metabolism and immune response and 
signaling were identified in pathway analyses as recurring functional themes with high 
significance and gene count. Figure 4 shows a subset of miR-mRNA interactions, where the 
genes interacting with miRs involved in lipid metabolism (6 genes) and immune response & 
signaling (23 genes) are highlighted. 
 
2.3.5 Relationship between HFC and NAFLD 
 
Hepatic fat content was examined for notable change among the normal and NAFLD groups, 
as well as the NAFLD subclasses, fatty liver, borderline NASH and NASH.  As expected, 
compared to normal liver samples, HFC was significantly higher in the NAFLD group, but 
HFC did not significantly differ among different NAFLD subgroups (Figure 5a, Figure S4).  
 
2.3.6 Relationship between HFC and selected co-variables 
 
We also explored for the confounding factors like age, gender and race, which might 
contribute to the variation of HFC across samples. We found no significant effect of race and 
gender on HFC content across samples as shown in Supplementary Figure S5.  However, 
age was found to be associated with HFC especially when liver samples from individuals’ ≥ 
45 years were compared to samples ≤ 18 years (p < 0.002, Figure 5b).  In order to test 
whether age contributes to the variance in expression levels of the 62 identified HFC-
associated miRNAs, PCA (Principle component analysis) was performed for examining the 
additive influence of age on the dysregulation of miRs across samples. This analysis 
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unambiguously revealed that more than 60% of the variance was explained by the first two 
principal components and age had small contribution to the loadings of either of the two 
components, as shown in Figure S6. Indeed, age did not have significant loading values in 
the first four principal components which together were able to explain more than 70% of the 
variance (Table S11). 
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Figure 4. Pathway specific post transcriptional network. HFC associated 62 miRs targeting 
genes, involved in important pathways viz. 23 genes in immune response and signaling 
(middle circle- orange) and 6 genes in lipid metabolism (inner circle- purple), was shown in 
an miR-target gene interaction network corresponding to a total of 327 connections (edges). 
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Figure 5. HFC associated miRs direct post transcriptional network changes in NAFLD: (a) 
Comparison of hepatic fat content between liver samples categorized to have normal liver 
histology and NAFLD; (b) Comparison of hepatic fat content  according to different age 
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groups; (c) MiR-mRNA (gene) association network with higher significance (p < 0.001) was 
generated and number of negatively correlated mRNA with HFC-associated miRs in each 
case, normal (33 samples) and NAFLD (16 samples) is shown as a bar graph. The degree of 
negative associations for HFC-associated miRs was significantly decreased in NAFLD as 
compared to normal livers (median [IQR] 110 [32-188] vs. 318 [223-411], p < 2.2e-16 by 
Wilcox test).  
 
 
2.3.7 Rewiring of post transcriptional network in NAFLD 
 
MiR-mRNA association network, where the expression levels of these molecules were 
negatively correlated (p < 0.001), was generated in NAFLD (16 samples) and normal (33 
samples) groups separately (Table S12). We observed that degree of negative associations 
for HFC-associated miRs was significantly decreased in NAFLD as compared to normal 
livers (median [IQR] 110 [32-188] vs. 318 [223-411], p < 2.2e-16 by Wilcox test) (Figure 5c).  
Similarly, as shown in Table S13, even after filtering these miRNA-mRNA associations for 
predicted miRNA targets by miRanda TargetScan algorithms, we found significantly fewer 
associations for NAFLD group compared to normal liver samples (median [IQR) 30 [4-56] vs. 
94 [36-152], p < 4.59e-10). These data strongly suggest that miR-mRNA post transcriptional 
regulatory network is highly dysfunctional in NAFLD.  
 
Sub-networks derived from Table S12, where the mRNAs were the predicted targets of 
miRNAs (Table S4), were constructed in normal and NAFLD samples. This allowed the 
calculation of degree ratio for 62 HFC associated miRs in normal and NAFLD samples 
allowing a comparison of the number of targets for each HFC associated miRNA in healthy 
and disease states (Table S13). We found that most HFC-associated miRs had differing 
number of associations in NAFLD compared to normal livers. In particular, a significant 
alteration in miR-mRNA interaction network was observed for miR-335, miR-19a, miR-30b, 
miR-26a and miR-20b (at least five-fold) with a decrease in the number of potential mRNA 
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targets in NAFLD samples.  Functional analysis of the targets of these miRNAs indicated 
enrichment for immune response, phagocytosis, focal adhesion and signaling pathways. It is 
worth noting all of these miRNAs were found to be negatively correlated with HFC and hence 
could act as protective players in inflammation and immune response. Indeed, mRNAs like 
LAMA1, MYO1F, PTGS1, GAS6, CLSTN1, IGKC and CD86 which were identified to be 
positively correlated with HFC (Table 2) were predicted to be controlled by several of these 
rewiring miRNAs. While a subset of miRNAs including miR-129-5p, mir-125b, miR-106b* and 
miR-100 exhibited intermediate level (between 2 to 5 fold decrease in the number of 
interactions) of rewiring. We also observed a slight increase for miR-122* in terms of the 
number of interactions (Table S13). Additionally, we tested whether the number of miRNA-
mRNAs interactions between normal and NAFLD groups differ when we filter the networks by 
including only the HFC mRNAs. Although the size of the networks were significantly smaller 
with degree information available in both normal and NAFLD groups for a subset of HFC 
miRNAs (marked in Table S13), we still found significantly fewer associations for NAFLD 
group compared to normal liver samples (p < 2.47e-4). 
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Chapter 3 Uncovering RNA binding proteins associated with age and gender during liver 
maturation 
 
3.1 Introduction 
 
Gene expression changes dynamically throughout the lifetime of an organism and the sub set of 
proteins expressed at each point in time allows cells to carry out important functions such as 
response to external stimuli, cell differentiation and development. These age related expression 
changes would influence the functioning of an organism. A study of post-mortem human brain 
tissue from 30 individuals aged 26 to 106 years showed that approximately 4% of the 11,000 
genes analysed show a significant age related expression change[68]. Another independent 
study examined healthy renal tissue removed at nephrectomy from 74 patients ranging in age 
from 27 to 92 years to identify ~1000 genes to be differentially expressed with age[69]. In 
addition, a significant difference in the expression of several genes encoding for antioxidant and 
detoxifying enzymes was seen in aged livers of both rats and human[70]. More recently, a study 
on age-dependent gene expression changes in 5 different tissues showed skin to have the most 
age related gene expression changes[71]. Similar to the age-related expression changes, it is 
also seen that genes express differently in the same organs of male and female. Recently, it 
was reported that though male and females share high similarity at genome level, most of the 
dimorphic traits are constrained to happen based on sex-biased gene regulation[72]. Another 
study that studied the sex based differences in the transcriptome of the human blood identified a 
gender specific expression in 582 autosomal genes of which 57.2% were up regulated in 
females [73]. It is also suggested that the gender based differences in epigenetic mechanisms 
may have profound consequences on brain development [74]. 
Although, the expression of genes varies based on age and gender, molecular mechanisms 
causing these differences still remain unclear.  Transcriptome changes could be largely 
attributed to difference in the levels of regulators participating at various stages of gene 
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expression. One such class of regulatory molecules are the RNA Binding Proteins (RBPs)-that 
bind RNA molecules to control different post transcriptional processes such as pre-mRNA 
splicing, mRNA cytoplasmic export, turnover, storage, and translation [13, 14]. Thus, the 
capacity of these proteins to influence gene expression at post-transcriptional level is extremely 
important especially during the developmental process to give rise to complex organs and 
tissues[15, 16]. For instance, PTBP1 (polypyrimidine tract binding protein), a ubiquitous protein 
known to be important in mammalian development at early stages of gastrulation[25, 26] and 
ELAVL1 (HuR) - a protein that acts as an mRNA stability factor, is also known for its role in 
placental branching, embryonic and neuronal development. [27, 28]. Likewise, CRD-BP 
(IGF2BP1), a member of the insulin-like growth factor 2 mRNA-binding protein family, is the first 
example of a putative mammalian mRNA-binding proteins that is abundant in fetal tissue but 
absent in the adult tissue [29].  
As is evident from the above examples, RBPs play a substantial role in mediating 
developmental changes of a mammalian cell.  Furthermore, a study on understanding the 
regulation of HNF4alpha in liver development revealed that the expression of HNF4aplha is 
widely regulated by the sequential promoter usage and alternative splicing in the 3’ end to 
produce different isoforms important for the liver development[30]. Yet another study identified 
UPF2, one of the key players of the non-sense mediated mRNA decay (NMD) machinery, as a 
critical regulator of the liver development[31]. Thus, although specific RBPs have been studied 
for their role in mediating developmental processes of liver, no global association analysis has 
been performed in humans to uncover the repertoire of RBPs contributing to liver development. 
Hence, to complement this gap in our global understanding about the functions of RBPs as 
developmental regulators in liver, in this study a genome-wide association analysis of their 
expression patterns with age and gender was conducted. To achieve this, we performed an 
association analysis of RBPs expression levels in human liver tissues with respect to age and 
gender, by integrating a dataset of 1344 genes experimentally known to encode for RBPs. This 
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allowed us to catalogue for the first time age and gender-related associations for RBPs as well 
as to study the wiring patterns of RBPs and their protein complexes (protein-protein interaction 
networks) with liver development in the human genome.  
 
3.2 Materials and Methods 
 
 
3.2.1 Data set of RNA-binding proteins and expression profiles for human liver tissues 
 
In the present study, we catalogued a set of 1344 genes encoding for RBPs in the human 
genome. This compendium comprised of proteins identified as RBPs in several recent 
experimental screens, including Castello et. al, [75], Baltz et. al. [76], Ray et. al, [77], human 
orthologs of RBPs identified in mouse embryonic stem cells by Kwon et. al, [78] and those 
reported in RBPDB [79]. 
In this study, we employed two different microarray-based liver expression cohorts for 
performing the association analysis. The first, a study by Innocenti et. al, which profiled 206  
normal human livers (183 European Americans and 23 African Americans) of which 74 were 
females and 132 males with age ranging from 1 to 81 years to map expression quantitative trait 
loci through genome wide association mapping (GSE25935) [32]. The second study by 
Schroder et. al, profiled 149 liver samples of Caucasian origin to identify expression quantitative 
loci (eQTL) in human liver of 71 females and 78 males ranging from 7 to 85 years of age 
(GSE32504) [80]. Data processing and normalization were carried out using the packages 
available in the R statistical framework. Raw expression data from GSE25935, generated using 
Agilent array was available in single colour format. This raw data was processed using limma 
package. For normalization we used a three step approach 1) for background correction 
(method = “normexp” and offset = 50) 2) for normalization between arrays (method = “quantile”) 
and finally 3) log transformation of the normalized data was performed. Secondly, in case of 
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GSE32504, raw data was generated using Illumina Bead Studio version 3 and thus beadarray 
[81] and lumi [82] packages from Bioconductor biocLite were used for processing of the raw 
data. Normalization of the raw data was carried out in a single step using quantile normalization 
approach. Figure 6A shows a generic flowchart summarizing the various steps involved in the 
data processing and analysis of the two microarray datasets. 
 
3.2.2 Associating the expression of RBPs with age and gender 
 
To test the association of expression with age and gender, we modelled the expression of each 
RBP as a dependent variable with age and gender as independent variables. Using the analysis 
of covariance -a statistical test used to explain the variance between independent and 
dependent variables, available from the R statistical framework we computed the significance of 
association. For each of the two microarray datasets, normalized expression of RBPs was 
simultaneously associated with the metadata - age and gender (Figure 6). Associations 
predicted at p<0.001 (FDR=5%, Benjamini-Hochberg [83] procedure) were considered 
significant. Thus, RBPs that were identified to significantly associate with age from either of the 
datasets were merged to form a non-redundant set. Similarly, a non-redundant set of RBPs 
associated with gender was obtained from the two datasets. 
 
Further, correlation analysis was performed between RBPs expression and age for the two 
datasets separately. Spearman correlation was calculated and p-value for each correlation 
association (expression vs age) was calculated. Associations identified at p <0.001 (FDR = 5%, 
Benjamini-Hochberg procedure) were considered significant. A similar approach was adopted to 
identify the associations of 1348 transcription factors extracted from DBD: Transcription factor 
prediction database[84] and ~18,000 Non-RBPs in the human genome. 
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3.2.3 Network dynamics of RBPs associated with age and gender 
 
We categorized the 1344 RBPs into two groups – those that are significantly associated with 
age (p<0.001 & FDR = 5%) in either of the two liver cohorts and the remaining genes that are 
not associated with age. A protein-protein interaction (PPI) network was constructed for each of 
the two groups of RBPs, using the publicly available experimentally verified interaction data 
from BioGRID database[85]. Age-associated RBP interaction network comprised of 47 nodes 
and 86 edges while the non-age associated RBP interaction network comprised of 1112 nodes 
and 9325 edges. Since the non-age associated network was significantly larger in terms of the 
number of nodes and edges, we employed a custom randomization model to generate random 
networks of the same size as the observed age-associated RBP network. In other words, the 
interaction network of proteins that are not associated with age was used to create 100 random 
networks each comprising of the same number of edges to serve as a control set. Briefly, let 
there be x number of edges in the network where RBPs are associated with age and y edges in 
the network not associated with age (assuming y > x). We obtained 100 random networks to 
represent control networks not associated with age and with each iteration we randomly 
obtained x edges and thus constructed 100 random networks with RBPs not associated with 
age interacting among themselves. The same protocol was applied to generate interaction 
networks for genes/proteins associated and non-associated with gender. Non-gender RBP 
interactions were then used to construct 100 random networks of RBPs not associated with 
gender. 
 
To study the properties of the PPI networks associated with age and gender, we used igraph, a 
publicly available R package for analyzing graphs [see http://cneurocvs.rmki.kfki.hu/igraph/ and 
http://www.r-project.org].  In particular, since the network of PPIs analyzed in this study is 
undirected, we used the corresponding versions of the functions: degree, clustering coefficient 
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(transitivity), betweenness and closeness for calculating the degree, clustering coefficient, 
betweenness and closeness centralities of a node. Betweenness centrality, which is the number 
of shortest paths going through a node was calculated using the brandes algorithm [86] 
implemented in R. Similarly, closeness, measured as the inverse of the average length of the 
shortest paths to all the other nodes in the graph, was obtained using the implementation in R. 
Since the centrality measures, betweenness and closeness use the shortest path lengths 
between all pairs of nodes in a graph, for cases where no path exists between a particular pair 
of nodes, shortest path length was taken as one less than the maximum number of nodes in the 
graph. Note that this is also the default assumption for calculating centrality measures in igraph. 
All the network centrality measures were compared between age-associated and non-age-
associated random RBP networks to study for differences in the distributions by performing non-
parametric tests. Similarly, gender-associated RBPs were compared for their corresponding 
network properties in non-associated random networks. 
 
3.2.4 Validation of the RBP associations in liver tissues of mouse and rat 
 
Mouse: 
Liver tissues were collected from mice at the indicated time points for mRNA expression 
analysis.  For further details regarding mice strain and age refer to Supplementary Table 4. 
Total RNA was isolated from mouse liver tissue using TRIzol. Total RNA (~5 μg) was reverse 
transcribed using Random Hexamer Primer (Thermo) and the Thermo Scientific Maxima 
Reverse Transcriptase kit.  Quantitative real-time PCR were performed in duplicates using 130 
ng of cDNA per reaction on an Eco Real-Time PCR system using Quanta PerfeCTa SYBR 
Green FastMix.  An initial activation step for 10 min at 95 °C was followed by 40 cycles of 95 °C 
for 10 s and 60 °C for 30 s.  Primer sequences used to measure relative steady-state 
expression of mRNA are provided in Supplementary Table 4.  Fold change of the mRNA was 
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calculated as previously described [87]. Data is presented as mean ± SEM.  
We followed the NIH Guide for the Use and Care of Laboratory Animals. The Institutional 
Animal Care and Use Committees of Universities of Illinois approved all experiments. 
 
Rat: 
The orthologs of 88 human RBPs associated with age in rat were extracted from the ENSEMBL 
compara, resulting in 65 corresponding genes. Expression profiles of these orthologs in 8 rat 
liver tissues RNA-sequenced at four developmental stages – 2 weeks, 6 weeks, 21 weeks and 
104 weeks were extracted from the Rat Body Map Database 
(http://pgx.fudan.edu.cn/ratbodymap/). This data was then used to the compare the expression 
patterns of RBPs between human and rat livers to identify the genes which followed the same 
trend as in humans. Heat maps were generated for RBPs which increased or decreased in both 
humans and rats (Supplementary Figure 2). 
 
3.3 Results 
 
 
3.3.1 RBPs exhibit significant alterations in their expression with aging human liver 
 
Association and correlation analysis revealed the expression of 88 RBPs to be significantly 
varying with age in human liver tissues (p<0.001, FDR=5%) (Figure 6, Materials and Methods, 
Supplementary Tables 1 and 2). These included 54 RBPs whose expression was observed to 
be increasing with aging liver (Figure 7A). Among these, LRPPRC – a leucine rich RNA Binding 
protein associated with post splicing nuclear RNP complexes and predominantly located within 
mitochondria [88] was found to have the highest correlation. Following this is  SUMO1- a 
qualified RBP identified from the interactome capture of the human HeLa cell lines [89]. In 
addition to these, we also capture one of the genes in the p53 developmental pathway – 
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ZMAT3, a zinc finger protein involved in the mRNA stability whose overexpression suppresses 
tumour growth [90, 91]. On the other hand, we found 34 genes to be significantly associated but 
negatively correlated with age (Figure 7B). For instance, we find PCDH20 – a novel member of 
the protocadherin gene family to be significantly negatively correlated with age. Moreover, an 
independent study has recently identified that the mRNA levels of this proteins to be down-
regulated in the hepatocellular carcinomas when compared to the disease free livers and thus 
functioning as a tumour suppressor [92]. Another notable example is PPIA – member of the 
peptidyl-prolyl cis-trans isomerase family known to accelerate the folding of proteins which in 
our analysis, was seen to negatively correlate with age. Additionally, a recent study proposed 
that stable expression of PPIA (or CypA) in liver cells confers resistance to anticancer drugs like 
doxorubicin and vincistrine [93] . In summary, we found 54 RBPs (61.4 %) to be positively 
correlated with age suggesting that the majority of the age-associated post-transcriptional 
control in liver is due to increased expression of RBPs indicating a potential for increased 
number of targets with age[14].  
 
Figure 6: Flowcharts summarizing the major steps involved in association and network analysis. 
A) Flowchart showing the various steps adopted for pre-processing and normalization of raw 
microarray data from both the liver cohorts followed by analysis of covariance between 
expression and metadata (age and gender) using functions in R statistical framework to identify 
the most significant associations. B) Flowchart showing the steps for construction of protein-
protein interaction (PPI) networks between RBPs associated with metadata (either age or 
gender) and a control set of 100 randomized PPI networks from RBPs not associated with 
metadata followed by the comparison of network properties between them.  
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Figure 7:  Expression patterns of RBPs associated with age. A) Heat map showing RBPs that 
are positively correlated with age (p<0.001, FDR<=5%) from both the cohorts in the study B) 
Heat map showing the list of RBPs that are negatively correlated with age (p<0.001, FDR 
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<=5%). Age ranges are shown from 0 to 100 years and expression levels are binned into 20 
year intervals. 
 
 
To know if the repertoire of proteins important for liver development is enriched for RBPs, we 
performed a similar association analysis for TFs and Non-RBPs (See Materials and Methods). 
This indicated that a higher proportion of RBPs are seen to be significantly associated (~6.5%) 
when compared to the TFs (~5.6%) and Non-RBPs (~5.4%) (p = 0.09, Fisher’s exact test). This 
strengthens the notion that RBPs are at least as important as other regulatory molecules 
implicated during liver development. 
 
3.3.2 Several RBPs showed similar changes in expression within aging mouse and rat liver 
tissue  
To validate whether our observations in the human liver samples are reproducible, we 
measured the relative fold change of the RBPs which showed strong positive correlation with 
age, using real-time-PCR in mouse liver for four different RBPs (see Materials and Methods) 
(Figure 8A).  In general, RBPs which showed increasing expression with age in human liver 
samples also showed a very similar trend in mouse liver.  As shown in Figure 8A, this trend is 
observed for Sumo1, Srsf4 and Mrpl42 which show a late and immediate increase in expression 
(> two-fold) at 10 months (Supplementary Table 3). 
Similar analysis was performed on four RBPs, which exhibited a strong negative correlation 
between expression and age, in the mouse liver (Figure 8B).  Of the four RBPs validated, Cstf1 
and Map4 exhibited strong decrease in expression levels with aging mice.  Ppia and Mkrn3 
followed decreasing trends in expression levels albeit weakly (Supplementary Table 3). 
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Figure 8: Expression levels measured using RT-PCR for eight RBPs in mouse for the time 
series ranging from postnatal 3 days to 10 months. X-axis shows the age of the mouse and y-
axis represents the average fold change in expression with standard error of mean shown for 
each time point. A) shows four RBPs tested in mouse model to see if the expression is 
positively correlated with age B) shows four RBPs tested in the mouse model which were found 
to be negatively correlated with age in the human samples. All the tested RBPs show strong 
correlation with age in the respective directions in human through our computational pipeline. 
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To further validate our findings, we extracted the expression profiles of these RBPs in rat 
livers (See Materials and Methods). We observed a strong reproducibility in the expression 
patterns of 33 human RBPs in the aging rat tissues (See Supplementary Figure 2). For 
example, we observe SUMO1, SYNCRIP and PDIA4 to be positively correlated while HADHB 
and PPRC were found to be negatively correlated with age in the rat livers. More generally, to 
study the enrichment of RBPs changing with age in human liver to be reproducible in the rat 
liver, we compared the proportions of the respective trends of the RBPs. RBPs increasing with 
age in human were found to be significantly enriched to be also detected as positively-
correlated with age in rat (p=0, Hypergeometric probability). We also found the RBPs 
decreasing with age in humans to be markedly over-represented to be negatively correlated 
with age in rat samples (p < 3.3e-13, Hypergeometric probability) suggesting that the 
observations are reproducible in mouse and rat genomes despite the variations in the samples 
and the absence of orthologs for several RBPs due to evolutionary divergence between the 
species. 
 
3.3.3 A small fraction of the RBPs are sexually dimorphic in humans 
Association analysis also enabled us to identify sex-specific RBP expression and to uncover 
variations between male and female samples (see Materials and Methods).  Briefly, this 
analysis revealed 45 RBPs whose expression was found to have a significant difference 
between genders (p < 0.001, FDR = 5%) (Supplementary Tables 1 and 2). We also found that a 
small set of these gender-associated RBPs (~40%) are up-regulated in males when compared 
to females. Several RBPs including WDR6, RBM4, GSPT1 and EIF1AX were found to be 
significantly differentially expressed between male and female samples (Figure 9). Of these, 
WDR6, member of the WD repeat protein family, implicated in the cell growth arrest was 
observed to be expressed at relatively higher levels in males. WD repeats are minimally 
conserved regions of around 40 amino acids generally bracketed by gly-his and trp-asp, which 
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may further facilitate multi-protein complex formation. It is known to enhance STK11/LKB1- 
induced cell growth suppression activity, a negative regulator of amino acid starvation–induced 
autophagy[94, 95]. Similarly, EIF1AX-eukaryotic translation initiation factor was observed to be 
expressed in higher levels in males than in females. In contrast, RBPs like GSTP1, LGAS1 and 
RBM4 were found to exhibit higher expression in females compared to males (Figure 4). 
Overall, our results suggest that a relatively smaller fraction of the RBPs are associated with 
gender compared to age in human liver and majority of these are up-regulated in females 
compared to males. 
3.3.4 Age-associated RBPs form a dense modular network of protein interactions 
 
RBPs attain their precise spatio-temporal control of gene expression most typically by forming 
protein complexes in the cell [96]. Therefore, to understand how the 88 RBPs, whose 
expression was found to be strongly associated with age in human samples, are interacting, we 
constructed a network of experimentally known protein-protein interactions (PPIs) between 
them. This was achieved using documented interactions between RBPs from the BioGRID 
database [85] (Materials and Methods). This resulted in a network of 86 protein-protein 
interactions between the age-associated RBPs (Figure 10). A closer inspection of the 
distribution of clustering coefficients of the nodes, which is a proxy for the modularity of the 
network, indicated that the network is significantly modular compared to random networks of the 
same size (Materials and Methods) (Supplementary Figure 1). Indeed, we found that the age-
associated RBP network exhibited twice the clustering coefficient than random networks (0.27 
vs 0.14 median clustering coefficient, p=2.2e-146, Wilcox test). Additional analysis to cluster the 
network into likely protein complexes indicated the presence of two high confidence protein 
complexes using ClusterONE [97] (Supplementary Table 5). One of these complexes comprised 
of ILF3, RPS26, FAU, SYNCRIP- a member of the cellular heterogeneous nuclear 
ribonucleoprotein (hnRNP) family and several members of the 60S ribosomal subunit. 
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Figure 9: Boxplots showing expression levels of selected set of RBPs which were found to be 
gender specific and thus are differentially expressed in male vs female samples in humans. All 
the comparisons are significant at p-value <= 0.05 (Wilcox test). 
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This dense network also comprised of SUMO1 and ILF3, forming hubs with highest number of 
interactions (Figure 10). Figure 10 also shows the edge betweenness (normalized) defined as 
the number of shortest paths going through an edge of interest and is analogous to the node 
betweenness, a centrality measure for nodes in a network (see Materials and Methods). We 
found a high edge betweenness score for the edge connecting SUMO1-protein whose 
expression increases with age and ILF3-protein whose expression decreases with age 
suggesting that there might be an inverse relationship in their stoichiometry with age to separate 
the age-related RNP complexes/network into different partitions. 
 
Figure 10: Protein interaction network of RBPs associated with age. Network showing the 
experimentally verified protein-protein interactions from the BioGRID database [85] between 
age-associated RBPs. Node colours vary between green and red signifying the extent of 
correlation of expression with age, with positively correlated RBPs coloured in red. Similarly, 
edge thickness and colour are highlighted with edge betweenness scores. Edges with higher 
edge betweenness centrality scores are shown in a thick red colour.  Network also highlights 
how RBPs positively and negatively correlated with age, interact among themselves to form 
dense modular RNP complexes. 
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3.3.5 Age and gender-specific associations in liver show significantly higher network centrality 
measures 
 
The importance of a protein can be assessed by measuring the centrality of a node in the PPI 
network. Centrality of a node can be measured by a number of different metrics including the 
most commonly used measures - degree, closeness and betweenness [98]. Therefore, to 
assess the significance of the centrality of the nodes in the age-associated RBP network, we 
compared the various centrality measures with that observed in a control set of random 
networks that contains a network of interactions among proteins that are not associated with 
age (see Materials and Methods). Normalized degree of the nodes in the network of proteins 
associated with age was found to be significantly higher than that seen in the control set 
(p=2.46e-52, Wilcox test) suggesting a higher connectivity among the age-associated RBPs 
(Figure 11A). Similarly, the distribution of closeness values was observed to be significantly 
different (p=1.97e-31, Wilcox test) and higher than the control set suggesting the existence of a 
denser network of interactions among proteins associated with age. The distribution of 
betweenness centrality scores were also found to be significantly different (p=1.33e-13, Wilcox 
test) and higher than the control set suggesting that these proteins are likely to play essential 
roles. Our results also suggest that these genes encoding for RBPs and strongly associated 
with age might form a dense and intertwined network of protein complexes contributing to the 
regulation of several age-related post-transcriptional processes in the liver tissue such as 
development and regeneration. Similar results were observed when we compared network of 
RBPs which expressed differentially in male vs female samples to the set of random networks of 
RBPs which are not gender specific (Figure 11B). In particular, we found that each of the 
centrality measures- degree, betweenness and closeness were significantly higher for gender-
associated RBPs compared to that seen in the random networks. 
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Figure 11: Boxplots for comparison of various network centrality measures A) between the 
networks of RBPs associated with age and not associated with age. The network of RBPs not 
associated with age comprises of an ensemble of 100 random networks constructed based on 
the randomization approach discussed in Materials and Methods section. Boxplots correspond 
to the comparison of normalized degree, betweenness and closeness values in the respective 
networks. All normalizations are based on the maximum value observed for the particular 
centrality measure in the corresponding network/s. B) between the networks of RBPs 
associated with gender and not associated with gender. The network of RBPs not associated 
with gender comprises of an ensemble of 100 random networks constructed based on the 
randomization approach discussed in Materials and Methods section. Boxplots correspond to 
the comparison of normalized degree, betweenness and closeness values in the respective 
networks. All normalizations are based on the maximum value observed for the particular 
centrality measure in the corresponding network/s. 
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Chapter 4 Discussion 
 
 
Over the past decade, although significant progress has been made in understanding the 
pathogenesis of NAFLD, the detailed molecular pathways underlying the disease process are 
not well understood.  Our study for the first time carried out a genome-wide integrated miR-
mRNA network analysis focusing on hepatic fat accumulation as an objective measure of 
NAFLD. The study revealed major dysregulated miRs controlling mRNAs significantly 
associated with hepatic fat accumulation. We also found that the miR-mRNA regulatory 
network was significantly rewired in NAFLD liver samples compared to normal livers. These 
findings provided important targets that foster strong rationale for further mechanistic 
validations and to investigate potential treatment targets. 
 
Our strategy aiming at the hepatic fat content as a quantitative objective measure of NAFLD 
allows us to identify genetic factors associated with NAFLD in a robust manner. Indeed, the 
list of functionally important miRs, as shown in Table 1, demonstrates the high confidence of 
our analysis. Many miRs identified in our analysis were linked  to NAFLD and NASH in 
previous studies, e.g. miR-122, the most studied miR in liver, is considered as biomarker 
involved in various liver diseases such as drug- and alcohol-induced liver disease, non-
alcoholic fatty liver disease, fibrosis, viral infections (hepatitis), cirrhosis and hepatocellular 
carcinoma [99]. Similarly, miR-34a, which was found significantly correlated with HFC (p ≤ 
0.003 with q ≤ 0.01) in our study, was previously documented as being dysregulated in 
multiple liver disorders (Table 1).  Apart from these two, some other miRs like miR-33b, miR-
378 and miR-125b were also extensively studied for their role in lipid metabolism [9, 100] 
further supporting the significance of our observations. Confirmation of these earlier 
observations in our study underscores the critical role that these “very important microRNAs” 
(VIMs) may play in the pathogenesis of NAFLD. In addition, several miRs identified in this 
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study to be associated with hepatic fat accumulation (e.g., miR-19b and miR-518b), which 
were also predicted to regulate multiple mRNAs associated with HFC, have not been 
reported in the context of liver diseases previously. How these miR-mRNA regulatory 
connections confer risk for NAFLD warrants further investigation. 
 
Our analysis also confidently identified a list of VIM-targeted genes that are associated with 
HFC and NAFLD. For instance, STMN2 was found in our analysis as a significant (p ≤ 3.36 
×10-5 with q < 0.001) and most positively associated gene with HFC. Our GO term analysis 
suggested its involvement in cell communication and developmental processes. This gene 
encodes for a phosphoprotein which helps in stabilizing cytoskeleton microtubule 
organization [101]. Our analysis showed a list of high confident post transcriptional regulators 
(i.e., miR-374a, miR-30b*, miR-887-5p, miR-129-5p, miR-142-3p, miR-885-5p, miR-204 and 
miR-122) that could modulate this gene in NAFLD.  This gene was reported to be significantly 
up-regulated in individuals with liver fibrosis [102]. Thus, it could be conjectured that 
dysregulation of this gene may confer susceptibility to the distortion of cytoskeleton 
organization in hepatocytes with fat accumulation and there by promoting ballooning and 
fibrosis. Similarly, LAMA1, encoding Laminin alpha 1, was the second most positively 
correlated gene with HFC, and was previously found to be involved in multiple biological 
processes including metabolism, signaling, communication, immunity, cell adhesion etc. from 
their GO term annotations. Laminin can interact with extracellular matrix components and 
mediate the attachment, migration and organization of cells within tissue during 
developmental processes. Its expression was reported to be 2.1 fold increased in NASH 
patients compared to normal steatosis patients [103], further supporting our observations. We 
found, miR-30a, b, c, d, e, and miR-26a and b, as major post transcriptional regulators for 
this gene. 
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Lipid metabolism and immune response were identified as most affected processes recurring 
in functional theme with high significance and gene count and this confirms a key role for 
dysregulated lipid metabolism and inflammation-related pathways in the pathogenesis of 
NAFLD.  HFC-associated 23 genes (Figure 4) belong to specific immunity and inflammation 
pathways like natural killer cell mediated cytotoxicity, Fc gamma R-mediated phagocytosis, 
steroid biosynthesis and IL-2 Receptor Beta Chain in T cell Activation provide the 
mechanistic information prone to molecular alteration as an effect of hepatic fat 
accumulation. For instance, one previous study suggested that dysregulation of Gas6 is 
implicated in the progression of steatosis to steatohepatitis and fibrosis in mice liver [104]. 
Our results identified two miRs significantly associated with HFC, miR-491-3p and miR-151-
5p, as major regulators of the Gas6 gene.  
 
Most interestingly, we found that the miR-mRNA network was significantly rewired between 
normal and NAFLD liver samples. Our results suggest that all the HFC-associated miRs 
identified in this study were likely to contribute to the rewiring of the post-transcriptional 
network in NAFLD to differing extents. In particular, most of the miRNA-mediated-dysfunction 
in NAFLD might be because of the decrease in the functionality of the miRNAs which would 
otherwise target higher number of transcripts in a healthy state. In other words, it can be 
hypothesized that the effective changes in miR-mRNA interaction in NAFLD for miRs like 
miR-19a, miR-26a is because, either they skip most of their targets due to influence of some 
unplugged thorn in NAFLD or they degraded an important post-transcriptional target as an 
immediate response during fat accumulation which is in turn responsible for triggering the 
decrease in the number of targets.  
 
Some aspects of our study deserve further comments. Our study is based on human liver 
samples obtained from transplant donors, which were subsequently characterized in terms of 
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their HFC and NAFLD.  It would be ideal to conduct this study on samples obtained from 
living humans but such a study design is very difficult because  it is challenging (a) to obtain 
liver samples from individuals with normal livers and (b) to obtain liver tissue of sufficient 
quantity to measure hepatic fat, protein, mRNA and miRs. One could argue that individuals 
undergoing bariatric surgery may serve as an avenue for obtaining liver samples of sufficient 
quantity, but morbidly obese undergoing bariatric surgery represent an extreme phenotype 
and thus may not reflect NAFLD as seen in the general population.  Another potential 
limitation of our study from a genomic view point is that our microarray platform for miRNAs 
does not include the recently identified novel miRNAs and hence the repertoire of miRNAs 
being reported here might be incomplete as there might be additional miRNAs which might 
be correlated with HFC belonging to the new families of miRNAs. A possible solution to 
address this problem is to perform RNA-seq of the samples in the future, which can provide a 
comprehensive overview of the complete set of miRNAs in the liver samples which are 
associated with HFC. Yet another potential limitation of our current dataset is that it does not 
shed light into the pathogenesis of nonalcoholic steatohepatitis (NASH) and advanced 
fibrosis. Our cohort lacked sufficient number of samples with NASH and advanced fibrosis. 
Future studies should focus of cohorts which are enriched with these advanced forms of 
NAFLD.  
 
In summary, our study for the first time provided detailed insights into the HFC-associated 
miR-mRNA regulatory network and these observations provide clues to better understand the 
pathogenesis and treatment targets of NAFLD. Our findings further highlighted the miRs and 
mRNAs previously identified, and more importantly generated a number of new hypotheses 
to be investigated in the future. Similar systems biology studies should be undertaken to 
better understand the pathogenesis of NASH and advanced fibrosis in humans.  
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Many studies to date have focused on genes that change with age and gender but the 
regulatory molecules mediating such mechanisms remain unclear. Previous studies have shown 
that eQTLs (expression Quantitative Trait Loci) interact with age and gender and play a major 
role in disease susceptibility[71, 105]. However, the contributing regulatory factors remain 
unclear. For instance, Masuda et. al, show that mRNA turnover and translation regulatory (TTR) 
RBPs show similar pattern in many tissues like gastrointestinal, urinary and immune systems in 
an age dependent manner [106]. This article emphasises that change in expression of a specific 
group of RBPs - important players in mRNA turnover and/or translation, as a function of age in 
human liver samples is an important but poorly studied level of association. However, post-
transcriptional control is mediated by several hundreds of RBPs in the human genome and our 
knowledge about their role in controlling age-associated processes is rather limited. Therefore, 
in this study, to address this problem, we have compiled two different liver expression cohorts 
and performed a global association analysis between hundreds of experimentally characterized 
RBPs in the human genome for the first time to uncover the compendium of RBPs varying with 
age and gender. We observe several RBPs to be changing in expression with age and gender 
suggesting an important role for post transcriptional regulation during liver development. 
Majority (~60%) of the age-associated RBPs were found to be increasing in their expression 
levels with age while a small set of gender-associated RBPs (~40%) were found to be up-
regulated in males. Several of these predicted associations were confirmed in the rat tissues 
and experimentally validated in a mouse model. This resulted in a significant number of human 
RBPs showing similar expression patterns in aging liver of rat and mouse, thus corroborating 
our findings. Further analysis of the protein interaction network of RBPs associated with age 
and gender based on the centrality measures like degree, betweenness and closeness revealed 
that several of these RBPs might be prominent players in liver development and impart gender 
specific alterations in gene expression via the formation of protein complexes. Furthermore, 
SUMO1 – gene which was positively correlated with age was observed to be sharing a highest 
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edge betweenness with ILF3 that was negatively correlated with age signifying a possible 
existence of a co-regulatory mechanism linking sumoylation and translational regulation – 
processes controlled by these respective proteins during liver development. This also suggests 
that the interaction between SUMO1 and ILF3 might facilitate a link between post transcriptional 
control, protein stability, nuclear cytosolic transport of proteins and translational control. It is 
worth mentioning that in this study we are only looking at a static network of physical 
interactions between RBPs associated with age (Figure 10). However, it is easy to note that this 
dynamic network might evolve/vary with age suggesting that varying sub-networks might be 
active depending on the developmental time frame and interplay with other cellular processes. 
So it is possible to speculate that there may be a time point in dynamics when the stoichiometry 
of the physical interactions between RBPs increasing and decreasing with age may disrupt 
leading to causative effects or disease phenotypes. With increasing high-resolution data from 
next generation sequencing and proteomics pipelines from hundreds of individuals it should be 
possible in the near future to understand such complex and rich set of associations between 
genes and proteins across cell types. Hence, this study will not only help us gain insight into the 
role of post-transcriptional regulatory molecules in aging and gender specific expression of 
genes but also provide a foundation for identifying the causative players contributing to the 
splicing eQTLs. 
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